Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Resource Library

Experimental Rationale for New and Emerging Therapies of Pulmonary Hypertensive Vascular Disease: What’s on the Horizon?

Stephen Archer


Reviews

  Sign in to add a review

0 comments
Leave a Comment

Conference: 2012 Neonatal and Childhood Pulmonary Vascular Disease Conference

Release Date: 06.19.2013

Presentation Type: General Sessions

This session was originally presented at the 5th Annual International Neonatal and Childhood Pulmonary Vascular Disease Conference.

Dr. Stephen L. Archer overviews potential therapeutic targets in this session from the 5th Annual International Neonatal and Childhood Pulmonary Vascular Disease Conference.  He also describes an experimental therapy that has been developed for treating non-small cell lung cancer and its potential implications to pulmonary hypertension.